| 000 | 01384 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515164307.0 | ||
| 264 | 0 | _c20090604 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a2040-3437 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIll, Charles R | |
| 245 | 0 | 0 |
_aRisk reduction in biotherapeutic products. _h[electronic resource] |
| 260 |
_bCurrent opinion in drug discovery & development _cMar 2009 |
||
| 300 |
_a296-304 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacteria _xisolation & purification |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 | _aBiosensing Techniques |
| 650 | 0 | 4 | _aCell Culture Techniques |
| 650 | 0 | 4 | _aConsumer Product Safety |
| 650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
| 650 | 0 | 4 |
_aEquipment Contamination _xprevention & control |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobiological Techniques |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aViruses _xisolation & purification |
| 700 | 1 | _aDehghani, Houman | |
| 773 | 0 |
_tCurrent opinion in drug discovery & development _gvol. 12 _gno. 2 _gp. 296-304 |
|
| 999 |
_c18770128 _d18770128 |
||